BREANNA KELZ: Open Payments
NPI 1760116354 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$151 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $151
Food & beverage: $151
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Lundbeck LLC | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| TMS NeuroHealth Centers Inc. | 1 | $16 |
Products named: REXULTI, HETLIOZ, CAPLYTA, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
